Scientists have discovered that electrical currents may make Natural Killer (NK) cells -- our very own cancer-killing immune cells -- even better killers, which could have significant implications for treating some cancers. The scientists found that Tumour Treating Fields (TTF) in the laboratory (which mimic exposure of brain tumors to electric currents via a simple
Scientists have discovered a way to turn the body's B cells into tiny surveillance machines and antibody factories that can pump out specially designed antibodies to destroy cancer cells or HIV, two of medicine's most formidable foes. USC scientists have discovered a way to turn the body's B cells into tiny surveillance machines and antibody
Scientists have discovered that electrical currents may make Natural Killer (NK) cells -- our very own cancer-killing immune cells -- even better killers, which could have significant implications for treating some cancers. The scientists found that Tumour Treating Fields (TTF) in the laboratory (which mimic exposure of brain tumors to electric currents via a simple
Scientists have discovered that electrical currents may make Natural Killer (NK) cells -- our very own cancer-killing immune cells -- even better killers, which could have significant implications for treating some cancers. The scientists found that Tumour Treating Fields (TTF) in the laboratory (which mimic exposure of brain tumors to electric currents via a simple
A simple blood test that measures the number of lymphocytes, a type of white blood cell in the body, may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according to new research. A simple blood test that measures the number of lymphocytes, a type of white blood
Scientists have discovered a way to turn the body's B cells into tiny surveillance machines and antibody factories that can pump out specially designed antibodies to destroy cancer cells or HIV, two of medicine's most formidable foes. USC scientists have discovered a way to turn the body's B cells into tiny surveillance machines and antibody
Elicit a natural immune response. This innovative approach aims to enhance the effectiveness of immunotherapy treatments and potentially improve outcomes for cancer patients. By utilizing engineered peptides, this method offers a promising new avenue for drug development and personalized cancer therapy. This research represents a significant advancement in the field of immunotherapy and has the potential to revolutionize the way we treat cancer
